| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02157272 2013-004575-13 Details | 2018-01-30 Interventional | 3 | 121 | Rivaroxaban Antiphospholipi… Syndrome | Unbalance in the composite endpoint between arms. - | |||
| NCT01682512 2011-002894-48 Details | 2018-01-30 Interventional | 3 | 294 | Rituximab Arthritis Arthritis, Rheu… | substance discontinued The study program was terminated and this study was discontinued on 3 September 2015. As a result no patients receiving study treatment in Part II of the study reached Week 24, and no conclusions regarding the efficacy of BI 695500 can be made. | |||
| NCT03363191 Details | 2018-01-29 Interventional | 4 | 0 | Albuterol Fluticasone Xhance Asthma | The study was withdrawn due to an internal decision. - | |||
| NCT02609048 Details | 2018-01-29 Interventional | 2 | 41 | Seladelpar Fibrosis Liver Cirrhosis Liver Cirrhosis… Primary Biliary… | Study stopped early after review of safety and efficacy demonstrated efficacy proof-of-concept
and need for dose reduction. - | |||
| NCT02221674 2014-000623-24 Details | 2018-01-29 Interventional | 2 | 40 | Tapentadol Pain, Postopera… Moderate to Sev… | - - | |||
| NCT02780882 Details | 2018-01-26 Interventional | 2 | 0 | Pasireotide ACTH Syndrome, … Cardiac Complex… Cushing Syndrom… Ectopic ACTH Sy… | Due to stringent inclusion/exclusion criteria, study investigator deemed it not feasible. - | |||
| NCT02539810 Details | 2018-01-26 Interventional | 4 | 4 | Antihypertensiv… Constriction, P… Hypertension Renal Artery Ob… Angiographicall… Hypertension Re… | - - | |||
| NCT00311558 Details | 2018-01-26 Interventional | 1 | 18 | Antimony Sodium… Interferon alph… Interferon-alph… Interferons Lymphoma Cancer | - - | |||
| NCT02975583 Details | 2018-01-25 Interventional | 4 | 0 | Vorapaxar Peripheral Arte… Peripheral Arte… | We could not secure adequate medication - | |||
| NCT02257619 Details | 2018-01-25 Interventional | 2 | 9 | Docetaxel Carcinoma, Non-… Lung Neoplasms NSCLC (Non-smal… | Sponsor decision to not initiate part 2 due to slow enrollment and competing trials. - | |||
| NCT01759407 Details | 2018-01-25 Interventional | 2 | 19 | Epinephrine Femoral Fractur… Fractures, Bone Traumatic Femur… | Interim analysis showed no significant difference between study arms. - | |||
| NCT01631513 Details | 2018-01-25 Interventional | 4 | 0 | Tapentadol Back Pain Low Back Pain Osteoarthritis Chronic Back Pa… Chronic Low Bac… Osteoarthritis … Pain | It was a business decision to cancel this study in Aug. 2012. - | |||
| NCT02578719 Details | 2018-01-23 Interventional | 4 | 0 | Bupivacaine Migraine Disord… | Local Drug Authority didn't give permission to start. - | |||
| NCT02176642 Details | 2018-01-23 Interventional | 4 | 55 | Oxybutynin Urinary Inconti… Urinary Urge In… | - - | |||
| NCT02134015 2013-004371-12 Details | 2018-01-23 Interventional | 3 | 145 | Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Lung Cancer Non-small Cell … | Pre-defined criteria for continuation were not reached - | |||
| NCT01655992 Details | 2018-01-23 Interventional | 3 | - | Capecitabine Tegafur Breast Neoplasm… Metastatic Brea… | The sponsor decided to stop the study. - | |||
| NCT01469988 Details | 2018-01-23 Interventional | 2 | - | Testosterone Heart Failure | Feasibility - | |||
| NCT01035801 Details | 2018-01-23 Interventional | 1 | 20 | Insulin Lispro Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes… | This study was temporarily paused due to an unanticipated bioanalytical issue. - | |||
| NCT00522548 Details | 2018-01-23 Interventional | 4 | 37 | Mycophenolic Ac… Transplants and… | enrollment halted in order to have all patients complete follow-up by Jan 2011 Limitations of our study include small sample size and patient drop out-though not significantly different between the MMF and EC-MPS groups and limited follow-up | |||
| NCT00176826 NCT00973843 Details | 2018-01-23 Interventional | 2/3 | 22 | Busulfan Chediak-Higashi… Hematologic Dis… Histiocytosis Histiocytosis, … Immune System D… Immunologic Def… Lymphohistiocyt… Lymphoprolifera… Syndrome Griscelli Syndr… Hemophagocytic … Immunologic Dis… Langerhans-Cell… X-Linked Lympho… | Replaced by another protocol - |